2023
Exports
$5.94BWorld Rnk 15 / 208
Flag Rnk 4 / 1210
2023
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.25Rnk 89 / 1025
2023
Imports
$2.78BWorld Rnk 20 / 222
Flag Rnk 8 / 1213
2023
ECONOMIC COMPLEXITY of Sweden
1.53Rnk 9 / 132

About

Exports In 2023, Sweden exported $5.94B in Vaccines, blood, antisera, toxins and cultures, making it the 15th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 4th most exported product in Sweden. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Sweden are: United States ($2.41B), Germany ($955M), France ($426M), Austria ($384M), and China ($347M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Sweden between 2022 and 2023 were United States ($1.16B), Russia ($163M), and South Korea ($149M).

Imports In 2023, Sweden imported $2.78B in Vaccines, blood, antisera, toxins and cultures, becoming the 20th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most imported product in Sweden. Sweden imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($784M), United States ($737M), Belgium ($297M), Netherlands ($251M), and Ireland ($121M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Sweden between 2022 and 2023 were Germany ($158M), Ireland ($83.5M), and South Korea ($30.2M).

Latest Trends

October 2024

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (October 2023 - October 2024)SEK-693M(-12.4%)
IMPORT GROWTH (October 2023 - October 2024)SEK-557M(-18.7%)
MAIN EXPORTER (October 2024)undefined6.9B
MAIN DESTINATION (October 2024)GermanySEK973M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Sweden. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$5.94B
IMPORTS (2023)$2.78B
NET TRADE (2023)$3.16B

In 2023, Sweden exported $5.94B in Vaccines, blood, antisera, toxins and cultures. The main destinations of Sweden exports on Vaccines, blood, antisera, toxins and cultures were United States ($2.41B), Germany ($955M), France ($426M), Austria ($384M), and China ($347M).

In 2023, Sweden imported $2.78B in Vaccines, blood, antisera, toxins and cultures, mainly from Germany ($784M), United States ($737M), Belgium ($297M), Netherlands ($251M), and Ireland ($121M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Sweden WERE (2022 - 2023):
United States$1.16B (93.7%)
Russia$163M (226%)
South Korea$149M (370%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Sweden WERE (2022 - 2023):
Singapore-$108M (-70.4%)
Ireland-$46.2M (-34.4%)
Egypt-$27.2M (-99.3%)

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, Sweden's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2023, Sweden's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $241M
TOP IMPORT POTENTIALSwitzerland+ $75.4M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is United States. With an export gap of $241M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Switzerland with an import gap of $75.4M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with